Back to search

Article

Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal Cancer

2021-02-05

Abstract excerpt

<h4>ABSTRACT</h4> Patients with colorectal cancer (CRC) frequently develop liver metastases during the course of their disease. A substantial proportion of them receive neoadjuvant FOLFOX (5-Fluorouracil, Oxaliplatin, Leucovorin) prior to surgery in an attempt to enable successful surgical removal of their metastases and to reduce the risk of recurrence. Yet, the majority of patients progress during treatment or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a4fd4df-d119-5ec6-b502-630d8ee0d20a
DOI
10.1101/2021.02.04.429849
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal CancerDOI 10.1101/2021.02.04.429849
Select a neighboring publication to make it the new centre.